XOMAO Stock Analysis: Buy, Sell, or Hold?
XOMAO - XOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock
$25.00
0.02 (0.08%)
â˛
5d:
+0.16%
30d:
-1.57%
90d:
-4.01%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Get Alerted When XOMAO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: XOMAO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: XOMAO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: XOMAO is currently trading at $25.00, which is considered fair based on recent price action.
Technical Outlook: Technically, XOMAO is showing sideways momentum. The price is currently testing key support at $25.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XOMAO is showing sideways momentum. The price is currently testing key support at $25.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
52/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
65.9%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$25.32
Resistance Level
$25.44
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Revenue Growth (YoY)
-22.6%
Earnings Growth (YoY)
207.9%
Profit Margin
69.6%
Share & Embed Analysis
Last updated: October 03, 2026 9:07 PM ET
Data refreshes hourly during market hours. Next update: 10:07 PM
Data refreshes hourly during market hours. Next update: 10:07 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XOMAO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 63 BUY |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
